2/8/24 16:30 | 2/7/24 | PCSA | Health | Drug | Pharmaceutical Preparations | Young David | MD | DO | P Resear | P | 52 | 2.45 | 0 | 21 | 18 | 140 | D | | | | | | | | | | | | | | |
2/7/24 16:22 | 2/6/24 | PCSA | Health | Drug | Pharmaceutical Preparations | Young David | MD | DO | P Resear | P | 51 | 2.53 | 0 | 20 | 20 | 119 | D | | | | | | | | | | | | | | |
2/1/24 18:32 | 1/31/24 | PCSA | Health | Drug | Pharmaceutical Preparations | Lin Patrick | MD | O | Chief Bu | P.m | 10 | 2.38 | 0 | 4 | 17 | 27 | D | | | | | | | | | | | | | | |
1/31/24 16:37 | 1/30/24 | PCSA | Health | Drug | Pharmaceutical Preparations | Ng George K | MD | DO | CEO | P | 27 | 2.70 | 0 | 10 | 100 | 20 | I | | | | | | | | | | | | | | |
1/31/24 16:34 | 1/30/24 | PCSA | Health | Drug | Pharmaceutical Preparations | Yorke Justin W | MD | D | | P | 22 | 2.69 | 0 | 8 | 30 | 35 | I | | | | | | | | | | | | | | |
6/12/23 16:31 | 6/12/23 | PCSA | Health | Drug | Pharmaceutical Preparations | Young David | MD | DOT | P,CEO | P | 32 | 0.8000 | 0 | 40 | 2 | 1,677 | D | | | | | | | | | | | | | | |
4/14/23 18:16 | 4/14/23 | PCSA | Health | Drug | Pharmaceutical Preparations | Young David | MD | DOT | P,CEO | P | 11 | 0.5499 | 0 | 20 | 1 | 1,637 | D | | | | | | | | | | | | | | |
4/13/23 16:51 | 4/11/23 | PCSA | Health | Drug | Pharmaceutical Preparations | Young David | MD | DOT | P,CEO | P.m | 29 | 0.4833 | 0 | 60 | 4 | 1,617 | D | | | | | | | | | | | | | | |
5/19/22 18:11 | 5/17/22 | PCSA | Health | Drug | Pharmaceutical Preparations | Lin Patrick | MD | O | Chief Bu | P | 3 | 1.59 | 0 | 2 | 0 | 433 | D | | | | | | | | | | | | | | |
4/8/22 16:49 | 4/6/22 | PCSA | Health | Drug | Pharmaceutical Preparations | Lin Patrick | MD | O | Chief Bu | P.m | 7 | 3.29 | 0 | 2 | 0 | 431 | D | | | | | | | | | | | | | | |
1/4/22 17:26 | 12/14/21 | PCSA | Health | Drug | Pharmaceutical Preparations | Lin Patrick | MD | O | Chief Bu | P | 12 | 4.00 | 0 | 3 | 1 | 429 | D | | | | | | | | | | | | | | |
12/16/21 16:37 | 12/14/21 | PCSA | Health | Drug | Pharmaceutical Preparations | Lin Patrick | MD | O | Chief Bu | P | 12 | 4.00 | 0 | 3 | 1 | 429 | D | | | | | | | | | | | | | | |
12/7/21 16:33 | 12/3/21 | PCSA | Health | Drug | Pharmaceutical Preparations | Lin Patrick | MD | O | Chief Bu | P | 17 | 4.80 | 0 | 4 | 1 | 426 | D | | | | | | | | | | | | | | |
8/30/21 16:33 | 8/26/21 | PCSA | Health | Drug | Pharmaceutical Preparations | Lin Patrick | MD | O | Chief Bu | P | 24 | 6.02 | 0 | 4 | 1 | 423 | D | | | | | | | | | | | | | | |
6/23/21 17:12 | 6/23/21 | PCSA | Health | Drug | Pharmaceutical Preparations | Young David | MD | DOT | CEO | P | 77 | 7.67 | 0 | 10 | 1 | 1,638 | D | | | | | | | | | | | | | | |
6/22/21 18:07 | 6/22/21 | PCSA | Health | Drug | Pharmaceutical Preparations | Floyd Robert Michael | MD | O | COO | P | 14 | 7.03 | 0 | 2 | 2 | 132 | D | | | | | | | | | | | | | | |
6/22/21 17:13 | 6/21/21 | PCSA | Health | Drug | Pharmaceutical Preparations | Lin Patrick | MD | O | Chief Bu | P | 13 | 6.65 | 0 | 2 | 1 | 402 | D | | | | | | | | | | | | | | |
6/22/21 17:09 | 6/21/21 | PCSA | Health | Drug | Pharmaceutical Preparations | Stanker James H | MD | O | CFO | P | 7 | 6.81 | 0 | 1 | 3 | 37 | D | | | | | | | | | | | | | | |
10/13/20 18:33 | 10/2/20 | PCSA | Health | Drug | Pharmaceutical Preparations | Besser James E | PR | T | | P | 121 | 4.04 | 0 | 30 | 2 | 1,530 | D | | | | | | | | | | | | | | |
10/5/20 17:33 | 10/1/20 | PCSA | Health | Drug | Pharmaceutical Preparations | Stanker James H | MD | O | CFO | P.a | 24 | 4.00 | 0 | 6 | 15 | 47 | D | | | | | | | | | | | | | | |
10/5/20 17:31 | 10/1/20 | PCSA | Health | Drug | Pharmaceutical Preparations | Lin Patrick | MD | O | Chief Bu | P.a | 125 | 4.00 | 0 | 31 | 8 | 400 | D | | | | | | | | | | | | | | |
10/5/20 16:43 | 10/1/20 | PCSA | Health | Drug | Pharmaceutical Preparations | Stanker James H | MD | O | CFO | P | 13 | 2.10 | 0 | 6 | 15 | 47 | D | | | | | | | | | | | | | | |
10/5/20 16:42 | 10/1/20 | PCSA | Health | Drug | Pharmaceutical Preparations | Lin Patrick | MD | O | Chief Bu | P | 66 | 2.10 | 0 | 31 | 8 | 400 | D | | | | | | | | | | | | | | |